Stay extended for US FTC's in-house antitrust case against PBMs
MLex Summary: A stay of the US Federal Trade Commissions' in-house enforcement action against pharmacy benefit managers Caremark Rx, OptumRx and their affiliated group purchasing organizations over allegedly inflated insulin prices...To view the full article, register now.
Already a subscriber? Click here to view full article